INTRODUCTION
Chloramphenicol acetyltransferase (CAT, EC 2.3.1.28) catalyses the O-acetylation of chloramphenicol, using acetylCoA as acetyl donor. The acetylated antibiotic does not inhibit protein synthesis as its fails to bind to bacterial ribosomes (reviewed by Shaw, 1983) .
Genes encoding CAT are commonly plasmid-borne, and CAT activity has been detected in a wide range of bacterial species. The amino acid sequences of seven CAT variants are known and show a marked degree of similarity to each other (Shaw & Leslie, 1989; Murray et al., 1989) . CAT is a trimeric enzyme of identical subunits of Mr 25000 (Leslie et al., 1986; Harding et al., 1987) .
Three general classes of CAT variants have been isolated from Gram-negative organisms, designated types I, II and III (Shaw, 1983 ). This classification is based upon differences in immunological cross-reactivity, electrophoretic mobility and sensitivity to reagents that modify cysteine residues (Gaffney et al., 1978) . The type I variant of CAT, unlike types II and III, binds the steroidal antibiotic fusidic acid with high affinity, thereby conferring resistance against this antibiotic (Bennett & Shaw, 1983) . The type II enzyme is exquisitely sensitive to inhibition by reagents that modify thiol groups, whereas types I and III are relatively insensitive (Gaffney et al., 1978; Murray et al., 1990) . The three-dimensional structure of a type III CAT variant (CAT111) has recently been determined. The gene for this catalytically efficient variant was isolated from plasmid R387 and can be expressed at high levels in Escherichia coli . The structure of the CAT,11-chloramphenicol binary complex has been refined to 0.175 nm resolution, and that of the CATIII-CoA complex to 0.24 nm (Leslie et al., 1988) .
CAT possesses three active sites per trimer, located equidistant from the threefold axis at the intersubunit interfaces. The chloramphenicol-binding and CoA-binding sites are largely composed of residues from one subunit, whereas a conserved histidine residue (His-195) required for catalysis is supplied by the opposing subunit. The chloramphenicol-binding and CoAbinding sites together form a tunnel through the protein, which is occupied by solvent in the absence of ligands (Leslie et al., 1988) .
The details of the CATIII structure explain data from steadystate kinetic analyses that indicated that CAT1 follows a ternarycomplex mechanism with random-order binding of substrates (Kleanthous & Shaw, 1984) . The importance of His-195 in the catalytic mechanism of CAT was inferred from chemicalmodification studies in which an active-site-directed reagent [3-(bromoacetyl) chloramphenicol] modified only the N-3 position of His-195 (Kleanthous et al., 1985) . In the crystal structure of the CAT111-chloramphenicol.complex the N-3 atom of His-195 is hydrogen-bonded to the 3-hydroxy group of chloramphenicol, which is the site of acetylation. The imidazole N-3 atom of His-195 is presumed to act as a general base during the CAT reaction, abstracting a proton from the primary hydroxy group of chloramnphenicol and promoting nucleophilic attack at the thioester carbonyl group of acetyl-CoA. In the absence of chloramphenicol, CAT catalyses the hydrolysis of acetyl-CoA at a rate approx. 104-fold lower than the rate of acetylation of chloramphenicol.
Early chemical-modification studies also demonstrated that some CAT variants are remarkably susceptible to inactivation by reagents that modify thiol groups (Zaidenzaig et al., 1979) . Since chloramphenicol protects against such inhibition, it was postulated that the reactive cysteine residue might be located at or near the active site of CAT. Examination of the structure of CAT111 indicates that Cys-31 is a prime candidate for the reactive thiol group, located as it is within the chloramphenicol-binding pocket close to . Cys-31 is present in most of the known CAT sequences; however, its substitution by threonine occurs in two staphylococcal CAT variants that are resistant to thiol-modifying reagents (Shaw, 1983 
MATERIALS AND METHODS

Materials
Reagents for chemical modification were obtained from the following sources: MMTS from Aldrich Chemical Co., DTNB, DTDP and iodoacetamide from Sigma Chemical Co., and iodoacetate from BDH Chemicals. Acetyl-CoA was prepared as described by Simon & Shemin (1953) .
Assay of CAT activity CAT activity was assayed spectrophotometrically at 25 'C. A modification of the method of Shaw (1975) was used to measure rates of chloramphenicol acetylation. The standard assay mixture contained TSE buffer, pH 7.5, 1 mM-DTNB, 0.1 mmchloramphenicol and 0.4 mM-acetyl-CoA. The reaction was initiated by the addition of enzyme, and the rate of formation of CoA was monitored by its reaction with DTNB and liberation of the thionitrobenzoate dianion (Amax 412 nm).
Rates of acetyl-CoA hydrolysis were determined exactly as above except that chloramphenicol was omitted from the reaction mixture. The amount of enzyme used in such assays of thioesterase activity (0.1-10 units) was much greater than that employed in the standard assay of chloramphenicol acetylation (0.004 unit). One unit of enzyme activity is defined as the amount converting 1 ,umol of substrate into product/min.
The concentrations of chloramphenicol and acetyl-CoA were varied in the standard assay mixture during kinetic analysis. Linear initial rates for steady-state kinetic analyses were measured over times during which less than 15 % depletion of substrates occurred. Kinetic parameters were determined from linear slope and intercept replots from manually drawn doublereciprocal plots (Kleanthous & Shaw, 1984) .
Site-directed mutagenesis and expression of CAT Oligonucleotide-directed mismatch mutagenesis was performed by using the deoxyuridine selection procedure with the dut ung E. coli strain RZ1032 (Kunkel et al., 1987) . The oligonucleotides were 5'-AAAACCAGATGGTAAA (one mismatch, Cys-31 --Ser), 5'-AGCTAAAACCAGCTGGTAAA-CGA (two mismatches, Cys-3 1 -+Ala), 5'-AGCTAAAACCAGT-TGGTAAACGA (two mismatches, Cys-31 -.Thr) and 5'-AGCTAAAACCCATTGGTAAACGA (three mismatches, Cys-31-+ Met). In each case the presence of the desired mutation and the absence of second-site mutations was confirmed by determination of the DNA sequence spanning the entire cat coding and 5' non-coding regions. Mutant cat determinants were over-expressed in E. coli after transfer to pUC 18 .
Purification of CAT
Purification of wild-type and mutant CAT from E. coli extracts was carried out by affinity chromatography on chloramphenicol-Sepharose as previously described (Lewendon et al., 1988) . The purity of enzyme preparations was assessed by SDS/PAGE (Laemmli, 1970) .
The concentration of purified CAT was calculated from the A2% = 13.1 or by the method of Lowry et al. (1951) with wildtype CATIII as standard.
Chemical modification of CAT
The time courses of chemical modification were monitored at 25°C in TSE buffer, pH 7.5. Stock solutions of iodoacetate, iodoacetamide, DTNB and MMTS were made up in TSE buffer and the pH was adjusted to 7.5 if necessary. These reagents were added to CAT in TSE Buffer, pH 7.5, at zero time. DTDP was added to incubations in acetonitrile, the final concentration of which was 0.95 M. This concentration of acetonitrile had no effect on CAT activity over the duration of incubations. At appropriate time intervals, samples were withdrawn, diluted in TSE buffer and assayed for CAT activity. DTNB. The final concentration of wild-type CAT was 0.4 mg/ml (16 ,uM). DTNB concentrations were varied between 0.25 mm and 2.0 mm. In experiments to assess the sensitivity of Cys-3 1-substituted CATs, the enzymes (0.225 mg/ml, 9 /icm) were incubated in a final concentration of 1 mM-DTNB for 30 h.
DTDP. The final concentration of wild-type CAT was 0.2 mg/ml (8 ,eM). DTDP concentrations were varied between 0.2 mm and 4 mm. The Cys-31-substituted CATs (0.45 mg/ml, 18 #M) were incubated in a final concentration of 0.2 mM-DTDP for 6 h.
MMTS. The final concentration of wild-type CAT was 0.09 mg/ml (3.6 fzM). MMTS concentrations were varied between 0.05 mm and 0.4 mm. The Cys-3 1-substituted CATs (0.225 mg/ml, 9 /tM) were incubated in a final concentration of 0.4 mM-MMTS for 60 min.
Re-activation of MMTS-modified CAT. Wild-type CAT (0.2 mg/ml, 8 cms monomers) was treated with 0.4 mM-MMTS for 15 min at 25°C in TSE buffer, pH 7.5. After this treatment, the CAT activity was 4.5 % of its initial value. Dithiothreitol was added to the MMTS-treated CAT to give a final concentration of 10 mm and this mixture was incubated at 25°C for 5 h. Samples were withdrawn at intervals and assayed for CAT activity.
Preparative MMTS modification of wild-type and [Met3"1CAT.
Both wild-type CAT and [Met31]CAT (0.5 mg/ml, 20/M) were incubated in 0.5 mM-MMTS for 2 h at 25 'C. Excess reagent was removed by dialysis against TSE buffer, pH 7.5, for 24 h at 4 'C.
Preparative DTDP modification of wild-type CAT. Wild-type CAT (4.8 mg/ml, 192 #M) was incubated in 3.6 mM-DTDP for 6 h at 25 'C. Excess reagent was removed by dialysis against TSE buffer, pH 7.5, for 24 h at 4 'C.
RESULTS AND DISCUSSION
Chemical modification of CATM11 lodoacetamide and iodoacetate. CAT1 activity is largely unaffected by treatment of the enzyme with iodoacetate; 0.1 Miodoacetate produced only a 10 % decrease in activity over 75 min. In contrast, iodoacetamide, its uncharged homologue, is an effective inhibitor of CAT,,, (Table 1) . (1)
where Kinact is (k I+ k+ )/k2l and is analogous to the Michaelis constant for a substrate and where tmin is the finite inactivation half-time (Meloche, 1967 Vol. 272 DTNB and DTDP. Under the conditions of modification (at pH 7.5), the anionic form of DTNB and the uncharged form of DTDP are the predominant species present. Again, CATIII is more resistant to the charged reagent than to the uncharged one (Table 1) . Since the inactivation of CAT by both disulphides shows rate saturation with increasing concentration of inhibitor, it follows that both these reagents bind to a site on the enzyme before the chemical-modification step. Protection against inactivation can be observed when chloramphenicol is present during the inactivation (results not shown). A comparison of ki/Inact values (analogous to kcat/Km) indicates that DTDP is a 48-fold better inhibitor of CATIII than is DTNB (Table 1) .
MMTS. MMTS modifies cysteine residues to produce the side-chain adduct -CH2-S-S--CH3 (Smith et al., 1975) . Treatment of CATIII with MMTS results in rapid inhibition of activity with no evidence of MMTS binding to CAT before inactivation (Table 1) . Again, chloramphenicol provides protection against inactivation. MMTS inactivation of CAT can be completely reversed by treatment of the modified enzyme with an excess of dithiothreitol. MMTS treatment does not totally inhibit CAT, since 4-5 % of the initial activity remains after extensive modification, and further addition of MMTS does not result in an additional decrease in activity. This contrasts with inactivation by DTDP, where approx. 0.5 % of the initial activity can be detected after modification.
The resistance of CAT1 to modification by charged reagents is entirely consistent with the hypothesis that the sites of action for these reagents (His-195 for iodoacetate and Cys-31 for DTNB) both lie within the chloramphenicol-binding pocket (Fig. 1) . This pocket is amphiphilic, reflecting the nature of the substrate (Leslie et al., 1988) . Cys-31, and to a lesser extent , are located within the more hydrophobic region of the chloramphenicol-binding site, which would tend to discriminate against the access of hydrophilic and charged reagents to these residues. The pre-modification binding of DTNB and DTDP is explained most economically by the fact that both of these reagents contain aromatic rings, which may fit into that part of the binding site normally occupied by the p-nitrophenol moiety of chloramphenicol.
Substitution of Cys-31 by alanine, serine, threonine or nmethionine Replacement of Cys-31 was accomplished by means of sitedirected mutagenesis as described in the Materials and methods section. The mutant enzymes were purified by affinity chromatography on chloramphenicol-Sepharose. Each CAT mutant was homogeneous as judged by SDS/PAGE, producing a single band of mobility identical with that of wild-type CAT.
The steady-state kinetic properties of wild-type and mutant enzymes are shown in Table 2 .
Cys-31--*Ala, Cys-31-.Ser or Cys-31-.Thr. The Cys-31 -.Ser substitution is the only one of those examined that does not produce a substantial decrease in catalytic activity, although it does result in a 3.6-fold increase in the Km value for chloramphenicol. Replacement Cys-31-*Met. The Cys-31-+Met substitution results in an enzyme with kinetic properties that are somewhat different from those noted above. Here the Km for chloramphenicol is unchanged whereas kcat is decreased 13-fold and the Km for acetyl-CoA is decreased 2.6-fold. Moreover, the kcat for [Met31]CAT in the acetyl-CoA hydrolysis reaction is increased 2.7-fold over the wild-type kcat. In fact, the Cys-31 -+Met substitution alters the specificity of CAT such that the ratio of the specificity constant The increases in the Km values for chloramphenicol observed for the alanine, serine and threonine replacements are readily explicable, as the site of mutagenesis is within the chloramphenicol-binding pocket. Although the side chain of Cys-31 is located within the chloramphenicol-binding site, it is not in van der Waal's contact with chloramphenicol. In fact, there is only a 0.5 nm3 change in the solvent-accessible area of Cys-31 on chloramphenicol binding (A. G. W. Leslie, unpublished work) . The closest approaches of Cys-31 to chloramphenicol are the 0.414 nm and 0.420 nm that separate the y-sulphur atom of this residue from two of the ring carbon atoms of chloramphenicol. The data presented in Table 3 suggest that the hydrophobicity of the side chain of residue 31 has a greater effect on chloramphenicol binding than does the volume of the residue. (Chothia, 1984) .
The hydrophobicity of the amino acid residue is taken as the free energy of transfer from water to ethanol (Nozaki & Tanford, 1971; Levitt, 1976) . The Km values for chloramphenicol are taken from The substitution of Cys-3 1 by methionine results in an enzyme that may be structurally similar to that produced on modification of CATM11 by MMTS. The inactivation of CAT by this reagent must be due to modification of Cys-31, as enzyme with the Cys-31 -+Met substitution is resistant to inactivation by MMTS (Table 4) . We have therefore compared the kinetic properties of MMTS-modified wild-type CAT with those of similarly treated [Met31]CAT. As noted above, MMTS treatment of wild-type CAT yields an enzyme with 4-5 % residual activity, whereas MMTS treatment of [Met3-]CAT causes no significant decrease in catalytic activity. After removal of excess reagent by dialysis there was no re-activation of wild-type CAT. A similar procedure was followed to produce DTDP-modified wild-type CAT. Here the enzyme was modified until only 0.8 % of the initial activity remained.
The kinetic properties of the MMTS-treated enzymes are shown in Table 5 . MMTS treatment of wild-type CAT results in a 2-fold increase in the Km for chloramphenicol, whereas the Km for acetyl-CoA is decreased 1.8-fold. However, the major consequence of MMTS modification of wild-type CAT is a large (28- (Table 5 ). This result is consistent with the presence of a bulky modifying group in the chloramphenicol-binding site.
CONCLUSIONS
Although studies of reactive thiol groups have made important contributions to the understanding of enzyme specificity and catalysis, it has not always been easy to draw firm conclusions from the results of chemical-modification studies. The advent of site-directed mutagenesis has simplified the task to some degree, but there remains the need to compare the two approaches to discern more clearly their respective advantages and limitations. The properties and location of a uniquely reactive thiol group (Cys-31) in CATIII suggested that its study might provide a clearer view of the factors contributing to the loss of activity observed in some systems coincident with the modification or replacement of non-essential cysteine residues close to substratebinding sites or catalytic centres.
The results described demonstrate that modification of Cys-3 1 is responsible for the inhibition of CAT activity resulting from treatment of CATIII with DTNB, MMTS and DTDP. Substitution of Cys-3 1 by site-directed mutagenesis results in enzymes that are resistant to inactivation by each of the above reagents. The discrimination observed in the effectiveness of uncharged as compared with anionic reagents as inhibitors of CATIII can be explained by noting that all of the reagents studied here are presumed to attack their target residues (Cys-31 or from within the hydrophobic portion ofthe chloramphenicolbinding pocket. Irrespective of whether the modification is preceded by a binding step (DTNB or DTDP) or not (MMTS or iodoacetamide), the non-polar nature of the environment of Cys-31 and His-195 probably discriminates against ionized ligands.
The kinetic properties of each of the Cys-3 1-substituted enzymes are significantly different from those of wild-type CAT.
Each substitution affected kcat, the Km for chloramphenicol or both parameters. In fact, none of the substitutions provided an entirely satisfactory replacement for Cys-31.
It has been possible to mimic the consequences of the Cys-31 -+Met substitution by modification of CAT111 by MMTS. The unnatural amino acid residue (R = -CH2-S-S-CH3) produced by chemical modification with MMTS is very similar in volume and only approx. 0.05 nm longer than a methionine residue (R = -CH2-CH2-S-CH3). This implies that the structure of [Met31] CAT is unlikely to differ from that of wild-type CAT except in the immediate environment of Met-31. This approach is feasible only when the protein of interest contains one uniquely reactive cysteine residue.
